Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients

被引:115
|
作者
Bahnassy, AA [1 ]
Zekri, ARN
El-Houssini, S
El-Shehaby, AMR
Mahmoud, MR
Abdallah, S
El-Serafi, M
机构
[1] Cairo Univ, Natl Canc Inst, Dept Pathol, Cairo, Egypt
[2] Cairo Univ, Natl Canc Inst, Dept Canc Biol, Virol & Immunol Unit, Cairo, Egypt
[3] Cairo Univ, Kasr El Eini Sch Med, Dept Biochem, Cairo, Egypt
[4] Cairo Univ, Kasr El Eini Sch Med, Dept Pathol, Cairo, Egypt
[5] Cairo Univ, Natl Canc Inst, Dept Med Oncol, Cairo, Egypt
关键词
D O I
10.1186/1471-230X-4-22
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Colorectal cancer is a common cancer all over the world. Aberrations in the cell cycle checkpoints have been shown to be of prognostic significance in colorectal cancer. Methods: The expression of cyclin D1, cyclin A, histone H3 and Ki-67 was examined in 60 colorectal cancer cases for co-regulation and impact on overall survival using immunohistochemistry, southern blot and in situ hybridization techniques. Immunoreactivity was evaluated semi quantitatively by determining the staining index of the studied proteins. Results: There was a significant correlation between cyclin D1 gene amplification and protein overexpression (concordance = 63.6%) and between Ki-67 and the other studied proteins. The staining index for Ki-67, cyclin A and D1 was higher in large, poorly differentiated tumors. The staining index of cyclin D1 was significantly higher in cases with deeply invasive tumors and nodal metastasis. Overexpression of cyclin A and D1 and amplification of cyclin D1 were associated with reduced overall survival. Multivariate analysis shows that cyclin D1 and A are two independent prognostic factors in colorectal cancer patients. Conclusions: Loss of cell cycle checkpoints control is common in colorectal cancer. Cyclin A and D1 are superior independent indicators of poor prognosis in colorectal cancer patients. Therefore, they may help in predicting the clinical outcome of those patients on an individual basis and could be considered important therapeutic targets.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients
    Abeer A Bahnassy
    Abdel-Rahman N Zekri
    Soumaya El-Houssini
    Amal MR El-Shehaby
    Moustafa Raafat Mahmoud
    Samira Abdallah
    Mostafa El-Serafi
    BMC Gastroenterology, 4
  • [2] Prognostic Potential of Cyclin D1 Expression in Colorectal Cancer
    Jun, Sun-Young
    Kim, Jiyoung
    Yoon, Nara
    Maeng, Lee-So
    Byun, Jae Ho
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (02)
  • [3] Prognostic significance of cyclin D1 over - expression in colorectal cancer
    Dhaoui, A.
    Aloui, D.
    Safer, M.
    Ben Rejeb, S.
    Aloui, M.
    Bahloul, R.
    Jomni, T.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S221 - S221
  • [4] Prognostic Value of IMP3 and Cyclin D1 Expression in Patients with Colorectal Cancer
    Mohamed, Salem Youssef
    Hafez, Abeer
    Elwan, Amira
    Abdelhamid, Mohamed, I
    Ahmed, Nabila Hassan
    Abdelmaksoud, Bader A.
    Abdelbary, Abeer M.
    MIDDLE EAST JOURNAL OF CANCER, 2022, 13 (01) : 57 - 66
  • [5] Cyclin D1 and cancer
    Garrett, MD
    Stockwell, S
    Taylor, K
    McAndrew, PC
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S115 - S116
  • [6] Expression of cyclin D1 and retinoblastoma protein in colorectal cancer
    Palmqvist, R
    Stenling, R
    Öberg, A
    Landberg, G
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (10) : 1575 - 1581
  • [7] Deregulation of cyclin D1 in cancer
    Michalides, R
    BIOLOGY OF TUMORS, 1998, : 127 - 143
  • [8] Cyclin D1 in breast cancer
    Barnes, DM
    Gillett, CE
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 1 - 15
  • [9] Cyclin D1 and breast cancer
    Roy, Pankaj G.
    Thompson, Alastair M.
    BREAST, 2006, 15 (06): : 718 - 727
  • [10] Cyclin D1 in Breast Cancer
    Diana M. Barnes
    Cheryl E. Gillett
    Breast Cancer Research and Treatment, 1998, 52 : 1 - 15